Pulmonary vascular disease

Self-help cognitive behavioural therapy for anxiety in pulmonary hypertension: pilot randomised controlled trial
Gregg H. Rawlings, Nigel Beail, Iain Armstrong, Andrew R. Thompson

ERJ Open Research Jan 2022, 8 (1) 00526-2021; DOI: 10.1183/23120541.00526-2021
Reply: External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension
Robin Condliffe, Kris Bauchmuller, Jennifer Southern, David G. Kiely, Gary H. Mills

ERJ Open Research Jan 2022, 8 (1) 00066-2022; DOI: 10.1183/23120541.00066-2022
Treatment of pulmonary hypertension associated with COPD: a systematic review
Ragdah Arif, Arjun Pandey, Ying Zhao, Kyle Arsenault-Mehta, Danya Khoujah, Sanjay Mehta

ERJ Open Research Jan 2022, 8 (1) 00348-2021; DOI: 10.1183/23120541.00348-2021
Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Krit Dwivedi, Robin Condliffe, Michael Sharkey, Robert Lewis, Samer Alabed, Smitha Rajaram, Catherine Hill, Laura Saunders, Peter Metherall, Faisal Alandejani, Dheyaa Alkhanfar, Jim M. Wild, Haiping Lu, David G. Kiely, Andrew J. Swift

ERJ Open Research Jan 2022, 8 (1) 00549-2021; DOI: 10.1183/23120541.00549-2021
Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome
Etienne-Marie Jutant, Guillaume Voiriot, Vincent Labbé, Laurent Savale, Hayat Mokrani, Patrick Van Dreden, Grigorios Gerotziafas, Muriel Fartoukh

ERJ Open Research Oct 2021, 7 (4) 00496-2021; DOI: 10.1183/23120541.00496-2021
Prothrombotic state in patients with stable COPD: an observational study
Christos Kyriakopoulos, Christos Chronis, Evaggelia Papapetrou, Athina Tatsioni, Konstantina Gartzonika, Christina Tsaousi, Athena Gogali, Christos Katsanos, Aikaterini Vaggeli, Charikleia Tselepi, Georgios Daskalopoulos, Stavros Konstantopoulos, Konstantinos Kostikas, Athanasios Konstantinidis

ERJ Open Research Oct 2021, 7 (4) 00297-2021; DOI: 10.1183/23120541.00297-2021
Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset
Joseph Newman, Iryna Boubriak, David Jenkins, Choo Ng, Alessandro Ruggiero, Nicholas Screaton, John Cannon, Mark Toshner

ERJ Open Research Oct 2021, 7 (4) 00431-2021; DOI: 10.1183/23120541.00431-2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension
Catherine E. Simpson, Megan Griffiths, Jun Yang, Melanie K. Nies, R. Dhananjay Vaidya, Stephanie Brandal, Lisa J. Martin, Michael W. Pauciulo, Katie A. Lutz, Anna W. Coleman, Eric D. Austin, D. Dunbar Ivy, William C. Nichols, Allen D. Everett, Paul M. Hassoun, Rachel L. Damico

ERJ Open Research Oct 2021, 7 (4) 00378-2021; DOI: 10.1183/23120541.00378-2021
Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial
Simon R. Schneider, Laura C. Mayer, Mona Lichtblau, Charlotte Berlier, Esther I. Schwarz, Stéphanie Saxer, Lu Tan, Michael Furian, Konrad E. Bloch, Silvia Ulrich

ERJ Open Research Oct 2021, 7 (4) 00314-2021; DOI: 10.1183/23120541.00314-2021
Improvement in exercise capacity after a modified Potts shunt in an adult patient with pulmonary arterial hypertension
Petr Symersky, Samara M.A. Jansen, Suzanne K. Kamminga, Lilian J. Meijboom, Erik J. Lust, Pirooz Eghtesady, Robert M. Grady, Harm J. Bogaard

ERJ Open Research Oct 2021, 7 (4) 00287-2021; DOI: 10.1183/23120541.00287-2021

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us